Although antiretroviral therapy effectively controls human immunodeficiency virus (HIV)
replication, a residual chronic immune activation/inflammation persists throughout the …

Antiretroviral therapy has largely transformed HIV infection into a chronic disease condition.
As such, physicians and other providers caring for individuals living with HIV infection need …

Background There are limited data regarding the clinical impact of coronavirus disease
2019 (COVID-19) on people living with human immunodeficiency virus (PLWH). In this …

With the wider availability of antiretrovirals, the world's HIV population is aging. More than
10% of the 34.5 million HIV-positive individuals worldwide are over the age of 50 years and …

Background The incidence of sudden cardiac death and sudden death caused by
arrhythmia, as determined by autopsy, in persons with human immunodeficiency virus (HIV) …

Background: The effect of human immunodeficiency virus (HIV) on the development of
peripheral artery disease (PAD) remains unclear. We investigated whether HIV infection is …

Although gut microbiota alteration and related blood microbe profiles in human
immunodeficiency virus (HIV)-infected individuals are associated with the disease …

When I was a junior faculty member at the University of Pittsburgh in the 1980s, one of my
first HIV-positive patients was a priest who worked in Chicago. He developed chronic weight …

Even after attainment of sustained viral suppression following implementation of highly
active antiretroviral therapy, HIV-infected persons continue to experience persistent, low …

Background: HIV-exposed-uninfected (HEU) infants have increased infectious morbidity and
mortality; little is known about their levels of inflammation and monocyte activation. Methods …